Site Search

Site Search

Displaying results 1 - 10 of 655

Crucial step towards EC regulatory approval of IMI-funded J&J Ebola vaccine

News | 29/05/2020 |
Studies indicate that the vaccine regimen is well tolerated, with robust and durable immune responses to the Zaire ebolavirus strain. Johnson & Johnson announced that its Janssen Pharmaceutical Companies received a positive opinion from the European Medicines Agency (EMA) for its ...
vaccine

An open letter in response to the GHA/CEO report on IMI

News | 25/05/2020 |
At IMI we are always open to justified, balanced, and constructive criticism of the model of public-private partnerships (PPPs) that is exemplified by IMI. We are the first to realise, as in any cutting edge collaborative model for biomedical research, that ongoing improvement ...

IMI2 – Call 22 & 23 webinars

Event | 15/06/2020 - 30/06/2020
IMI will hold webinars on IMI2 – Call 22 & 23 from Monday 15 June to Tuesday 30 June inclusive. All webinars on the Call topics will feature a presentation by the EFPIA topic coordinator and time for questions and answers. The webinars represent an excellent opportunity to learn ...

The story so FAIR

News | 13/05/2020 |
Making data FAIR could supercharge medicine development. FAIRplus is putting the principles into practice.
analytics

IMI announces COVID projects, boosts funding pot to EUR 72 million

News | 12/05/2020 |
Brussels, Belgium, 12 May 2020 – The Innovative Medicines Initiative has provisionally selected 8 projects for funding from its fast-track Call for proposals on coronavirus diagnostics and treatments. In addition, it has boosted the IMI funding pot from EUR 45 million to EUR 72 ...
SARS-CoV-2 virus. Image credit: National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH

8 new COVID-19 projects announced

News | 12/05/2020 |
The Innovative Medicines Initiative has provisionally selected 8 projects for funding from its fast-track Call for proposals on coronavirus diagnostics and treatments. In addition, it has boosted the IMI funding pot from EUR 45 million to EUR 72 million. On top of this, EFPIA ...
sars-cov2